ROBERTS EIRY 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Dec 19, 2024
Insider Transaction Report
Form 4
ROBERTS EIRY
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2024-12-17+5,487→ 5,487 total→ Common Stock (5,487 underlying) - Award
Stock Option
2024-12-17+27,770→ 27,770 totalExercise: $136.69Exp: 2034-12-17→ Common Stock (27,770 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
- [F2]The Restricted Stock Units will vest 1/4 of the units on February 13, 2025, and then annually 1/4 of the shares will vest on February 13, 2026, February 13, 2027, and February 13, 2028.
- [F3]Represents an option of which 1/4 of the shares underlying the option becomes vested and exercisable on February 13, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter beginning on March 13, 2025, such that the option shall fully vest on February 13, 2028.